Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Prossomariti, Anna ^a,b   Scaioli, Eleonora ^a   Piazzi, Giulia ^b   Fazio, Chiara ^a,b   Bellanova, Matteo ^a   Biagi, Elena ^a   Candela, Marco ^a   Brigidi, Patrizia ^a   Consolandi, Clarissa ^c   Balbi, Tiziana ^b   Chieco, Pasquale ^b   Munarini, Alessandra ^a,b   Pariali, Milena ^b   Minguzzi, Manuela ^a,b   Bazzoli, Franco ^a   Belluzzi, Andrea ^b   Ricciardiello, Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; FATTY ACID; HES1 PROTEIN, HUMAN; ICOSAPENTAENOIC ACID; IL10 PROTEIN, HUMAN; INTERLEUKIN 10; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 4; SOCS3 PROTEIN, HUMAN; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR HES 1;

ADULT; AGED; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PHOSPHORYLATION; PILOT STUDY; TREATMENT OUTCOME; ULCERATIVE COLITIS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COLITIS, ULCERATIVE; EICOSAPENTAENOIC ACID; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-10; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MICROBIOTA; MIDDLE AGED; PHOSPHORYLATION; PILOT PROJECTS; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING 3 PROTEIN; TRANSCRIPTION FACTOR HES-1; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85027029052     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-07992-1     Document Type: Article

References (59)

1. Beaugerie, L., & Itzkowitz, S. H. Cancers Complicating Inflammatory Bowel Disease. N. Engl. J. Med. 373, 195 (2015
2. Cairns, S. R., et al. Guidelines for colorectal cancer screening, and surveillance in moderate, and high risk groups (update from 2002). Gut 59, 666-89 (2010
3. Choi, C.-H. R., et al. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview. Am. J. Gastroenterol. 110, 1022-1034 (2015
4. Pineton de Chambrun, G., Peyrin-Biroulet, L., Lémann, M., & Colombel, J.-F. Clinical implications of mucosal healing for the management of IBD. Nat. Rev. Gastroenterol. Hepatol. 7, 15-29 (2010
5. Poullis, A., Foster, R., Mendall, M. A., & Fagerhol, M. K. Emerging role of calprotectin in gastroenterology. J. Gastroenterol. Hepatol. 18, 756-62 (2003
6. Mooiweer, E., Fidder, H. H., Siersema, P. D., Laheij, R. J. F., & Oldenburg, B. Fecal calprotectin testing can identify ineffective colorectal cancer surveillance procedures in patients with longstanding colitis. Inflamm. Bowel Dis. 20, 1079-84 (2014
7. Grivennikov, S., et al. IL-6, and Stat3 Are Required for Survival of Intestinal Epithelial Cells, and Development of Colitis-Associated Cancer. Cancer Cell 15, 103-113 (2009
8. Sturlan, S., et al. Interleukin-10-deficient mice, and inflammatory bowel disease associated cancer development. Carcinogenesis 22, 665-71 (2001
9. Johansson, M. E. V., et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models, and patients with ulcerative colitis. Gut 63, 281-291 (2014
10. Chu, H., et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science 352, 1116-20 (2016
11. Tjalsma, H., Boleij, A., Marchesi, J. R., & Dutilh, B. E. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat. Rev. Microbiol. 10, 575-82 (2012
12. Neurath, M. F. New targets for mucosal healing, and therapy in inflammatory bowel diseases. Mucosal Immunol. 7, 6-19 (2014
13. Katz, J. P., et al. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129, 2619-28 (2002
14. Piazzi, G., et al. Eicosapentaenoic acid free fatty acid prevents, and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling, and gut microbiota. Int. J. cancer 135, 2004-13 (2014
15. Ghaleb, A. M., Laroui, H., Merlin, D., & Yang, V. W. Genetic deletion of Klf4 in the mouse intestinal epithelium ameliorates dextran sodium sulfate-induced colitis by modulating the NF-κB pathway inflammatory response. Inflamm. Bowel Dis. 20, 811-20 (2014
16. Sartor, R. B., & Mazmanian, S. K. Intestinal Microbes in Inflammatory Bowel Diseases. Am. J. Gastroenterol. 1(Suppl.), 15-21 (2012
17. Terdiman, J. P., Steinbuch, M., Blumentals, W. A., Ullman, T. A., & Rubin, D. T. 5-Aminosalicylic acid therapy, and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm. Bowel Dis. 13, 367-71 (2007
18. Lasry, A., Zinger, A., & Ben-Neriah, Y. Inflammatory networks underlying colorectal cancer. Nat. Immunol. 17, 230-40 (2016
19. Arterburn, L. M., Hall, E. B., & Oken, H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 83, 1467S-1476S (2006
20. Obata, Y., et al. Epithelial cell-intrinsic Notch signaling plays an essential role in the maintenance of gut immune homeostasis. J. Immunol. 188, 2427-36 (2012
21. Biagi, E., et al. Gut Microbiota, and Extreme Longevity. Curr. Biol. 26, 1480-5 (2016
22. Eltweri, A. M., et al. Potential applications of fish oils rich in omega-3 polyunsaturated fatty acids in the management of gastrointestinal cancer. Clin. Nutr. 36, 65-78 (2017
23. Subramanian, V., & Logan, R. F. Chemoprevention of colorectal cancer in inflammatory bowel disease. Best Pract. Res. Clin. Gastroenterol. 25, 593-606 (2011
24. Vermeire, S., Van Assche, G., & Rutgeerts, P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55, 426-31 (2006
25. Sandborn, W. J., et al. Correlation Between Concentrations of Fecal Calprotectin, and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial. Gastroenterology 150, 96-102 (2016
26. Song, M., et al. Marine ?-3 polyunsaturated fatty acids, and risk of colorectal cancer according to microsatellite instability. J. Natl. Cancer Inst. 107 (2015
27. Fini, L., et al. Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in Apc(Min/+) mice. Clin. Cancer Res. 16, 5703-11 (2010
28. Cockbain, A. J., Toogood, G. J., & Hull, M. A. Omega-3 polyunsaturated fatty acids for the treatment, and prevention of colorectal cancer. Gut 61, 135-149 (2012
29. Matsunaga, H., et al. Omega-3 fatty acids exacerbate DSS-induced colitis through decreased adiponectin in colonic subepithelial myofibroblasts. Inflamm. Bowel Dis. 14, 1348-57 (2008
30. Jia, Q., et al. Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res. 68, 3985-91 (2008
31. Ananthakrishnan, A. N., et al. Long-term intake of dietary fat, and risk of ulcerative colitis, and Crohn?s disease. Gut 63, 776-84 (2014
32. Davidson, L. A., et al. Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation, and progression in the rat. Cancer Res. 64, 6797-804 (2004
33. Suzuki, A., et al. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation, and intestinal inflammation. J. Exp. Med. 193, 471-81 (2001
34. Pickert, G., et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206, 1465-72 (2009
35. Li, Y., et al. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis, and ulcerative colitis-related carcinogenesis. Gut 59, 227-35 (2010
36. Xu, A. T., et al. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission. Inflamm. Bowel Dis. 21, 241-50 (2015
37. Li, Y., et al. Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis. Inflamm. Bowel Dis. 19, 132-40 (2013
38. Tone, M., Powell, M. J., Tone, Y., Thompson, S. A., & Waldmann, H. IL-10 gene expression is controlled by the transcription factors Sp1, and Sp3. J. Immunol. 165, 286-91 (2000
39. Ma, W., et al. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 276, 13664-74 (2001
40. Sharma, A., et al. Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a. Proc. Natl. Acad. Sci. USA 106, 5761-6 (2009
41. Haan, S., et al. Tyrosine phosphorylation disrupts elongin interaction, and accelerates SOCS3 degradation. J. Biol. Chem. 278, 31972-9 (2003
42. Sasaki, A., et al. The N-terminal truncated isoform of SOCS3 translated from an alternative initiation AUG codon under stress conditions is stable due to the lack of a major ubiquitination site, Lys-6. J. Biol. Chem. 278, 2432-6 (2003
43. Reedijk, M., et al. Activation of Notch signaling in human colon adenocarcinoma. Int. J. Oncol. 33, 1223-9 (2008
44. Zhao, W., et al. Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 23, 395-402 (2004
45. Garg, P., et al. Notch1 regulates the effects of matrix metalloproteinase-9 on colitis-associated cancer in mice. Gastroenterology 141, 1381-92 (2011
46. Fazio, C., et al. Inflammation increases NOTCH1 activity via MMP9, and is counteracted by Eicosapentaenoic Acid-free fatty acid in colon cancer cells. Sci. Rep. 6, 20670 (2016
47. Fazio, C., & Ricciardiello, L. Inflammation, and Notch signaling: a crosstalk with opposite effects on tumorigenesis. Cell Death Dis. 7, e2515 (2016
48. Johansson, M. E. V., et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models, and patients with ulcerative colitis. Gut 63, 281-91 (2014
49. Ghaleb, A. M., McConnell, B. B., Kaestner, K. H., & Yang, V. W. Altered intestinal epithelial homeostasis in mice with intestinespecific deletion of the Krüppel-like factor 4 gene. Dev. Biol. 349, 310-320 (2011
50. Hasnain, S. Z., et al. IL-10 Promotes Production of Intestinal Mucus by Suppressing Protein Misfolding, and Endoplasmic Reticulum Stress in Goblet Cells. Gastroenterology 144, 357-368.e9 (2013
51. Rajilic-Stojanovic, M., Shanahan, F., Guarner, F., & de Vos, W. M. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm. Bowel Dis. 19, 481-8 (2013
52. Fischbach, M. A., & Sonnenburg, J. L. Eating for two: how metabolism establishes interspecies interactions in the gut. Cell Host Microbe 10, 336-47 (2011
53. Scaioli, E., et al. Clinical application of faecal calprotectin in ulcerative colitis patients. Eur. J. Gastroenterol. Hepatol. 27, 1418-24 (2015
54. Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N. Engl. J. Med. 317, 1625-9 (1987
55. Geboes, K., et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47, 404-9 (2000
56. Mooiweer, E., et al. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission. J. Crohns. Colitis 9, 50-5 (2015
57. Holland, T. The comparative power of the discriminant methods used in toxicological pathology. Toxicol. Pathol. 33, 490-4 (2005
58. Scaioli, E., et al. The Pharmacokinetic Profile of a New Gastroresistant Capsule Preparation of Eicosapentaenoic Acid as the Free Fatty Acid. Biomed Res. Int. 2015, 1-8 (2015
59. Snedecor, G., & Cochran, W. Statistical Methods. (Iowa State University Press, 1989